Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
494 studies found for:    "Diabetic Angiopathies"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetic Angiopathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients
Conditions: Foot Ulcer, Diabetic;   Diabetic Angiopathies
Intervention: Drug: bemiparin (low molecular weight heparin)
2 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
3 Completed Trial Comparing Different Medical Devices for Infragenual Dilatation
Conditions: Diabetic Angiopathies;   Intermittent Claudication
Interventions: Procedure: Infragenual dilatation;   Procedure: Infragenual dilatation with stenting;   Procedure: Infragenual dilatation with cutting balloon;   Procedure: Laser therapy
4 Completed Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Retinal Diseases;   Eye Diseases;   Diabetic Angiopathies;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy
5 Unknown  Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
Conditions: Disease Management;   Diabetes Complications;   Diabetic Vascular Complications;   Diabetic Neuropathy;   Diabetic Nephropathy;   Diabetic Retinopathy
Intervention: Other: ADEC Program
6 Completed Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
Condition: Diabetic Vascular Complications
Intervention:
7 Completed
Has Results
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen® pegaptanib sodium
8 Recruiting Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Interventions: Other: AMNIOEXCEL;   Other: Standard of Care, Diabetic Foot Ulcers
9 Recruiting Measurement of Endothelial Function With Peripheral Arterial Tonometry in Patients Undergoing Hyperbaric Oxygen Therapy
Condition: Diabetic Peripheral Vascular Disease
Intervention:
10 Completed Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Insulin glargine
11 Completed Effect of the Adjunctive IVB Before PRP
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab
12 Completed Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography
Conditions: Diabetic Retinopathy;   Age-Related Macular Degeneration;   Macular Edema
Intervention:
13 Withdrawn A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Procedure: islet cell transplant;   Other: Medical therapy
14 Unknown  Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)
Conditions: Diabetic Retinopathy;   Macular Degeneration
Intervention: Drug: intravitreal injection of infliximab
15 Completed Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: Ranibizumab (Lucentis);   Procedure: Argon Laser
16 Completed Electrical Stimulation and Expression of VEGF and NO in Diabetic Foot Ulcer
Condition: Diabetic Foot Ulcer
Interventions: Device: Electrical Stimulation (BTL-5000 series, United Kingdom);   Device: placebo
17 Completed A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
Condition: PDR
Intervention: Drug: Macugen (Pegaptanib Sodium)
18 Recruiting Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Conditions: Diabetic Foot;   Venous Ulcer;   Pressure Ulcer
Intervention: Drug: Adipose derived stem cells
19 Completed 20- Versus 23- Gauge System for Pars Plana Vitrectomy
Conditions: Diabetic Retinopathy;   Macular Edema;   Postoperative Complications;   Vitreous Hemorrhage
Intervention: Device: 20- and 23 gauge vitreoretinal surgery systems
20 Suspended Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Diabetic Macula Edema;   Proliferative Diabetic Retinopathy
Interventions: Drug: bevacizumab;   Drug: Ranibizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years